These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 21893447)
1. Neutrophil predominance in induced sputum from asthmatic patients. Therapeutic implications and role of clara cell 16-KD protein. Uribe Echevarría EM; Maldonado CA; Uribe Echevarría AM; Aoki A Medicina (B Aires); 2011; 71(4):343-9. PubMed ID: 21893447 [TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma. Strauch E; Moske O; Thoma S; Storm Van's Gravesande K; Ihorst G; Brandis M; Kuehr J Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396 [TBL] [Abstract][Full Text] [Related]
3. Effect of budesonide and montelukast in asthmatic children exposed to relevant allergens. Peroni D; Bodini A; Miraglia Del Giudice M; Loiacono A; Baraldi E; Boner AL; Piacentini G Allergy; 2005 Feb; 60(2):206-10. PubMed ID: 15647042 [TBL] [Abstract][Full Text] [Related]
4. The effect of montelukast on eosinophil apoptosis: induced sputum findings of patients with mild persistent asthma. Abadoglu O; Mungan D; Aksu O; Erekul S; Misirligil Z Allergol Immunopathol (Madr); 2005; 33(2):105-11. PubMed ID: 15808118 [TBL] [Abstract][Full Text] [Related]
5. Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma. Jayaram L; Duong M; Pizzichini MM; Pizzichini E; Kamada D; Efthimiadis A; Hargreave FE Eur Respir J; 2005 Jan; 25(1):41-6. PubMed ID: 15640321 [TBL] [Abstract][Full Text] [Related]
6. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma. Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601 [TBL] [Abstract][Full Text] [Related]
7. Effects of montelukast and budesonide on airway responses and airway inflammation in asthma. Leigh R; Vethanayagam D; Yoshida M; Watson RM; Rerecich T; Inman MD; O'Byrne PM Am J Respir Crit Care Med; 2002 Nov; 166(9):1212-7. PubMed ID: 12403690 [TBL] [Abstract][Full Text] [Related]
8. [Effectiveness and safety of montelukast versus budesonide at various doses on bronchial reactivity in subjects with mild persistent asthma]. Riccioni G; D'Orazio N; Di Ilio C; Della Vecchia R; De Lorenzo A Clin Ter; 2002; 153(5):317-21. PubMed ID: 12510415 [TBL] [Abstract][Full Text] [Related]
9. Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness. Green RH; Brightling CE; McKenna S; Hargadon B; Neale N; Parker D; Ruse C; Hall IP; Pavord ID Eur Respir J; 2006 Jun; 27(6):1144-51. PubMed ID: 16455831 [TBL] [Abstract][Full Text] [Related]
10. Safety and application of induced sputum analysis in childhood asthma. Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559 [TBL] [Abstract][Full Text] [Related]
11. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients. Basyigit I; Yildiz F; Ozkara SK; Boyaci H; Ilgazli A Mediators Inflamm; 2004 Aug; 13(4):285-91. PubMed ID: 15545060 [TBL] [Abstract][Full Text] [Related]
12. Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma. Szefler SJ; Carlsson LG; Uryniak T; Baker JW J Allergy Clin Immunol Pract; 2013 Jan; 1(1):58-64. PubMed ID: 24229823 [TBL] [Abstract][Full Text] [Related]
13. Single-dose desloratadine and montelukast and allergen-induced late airway responses. Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343 [TBL] [Abstract][Full Text] [Related]
14. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma. Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871 [TBL] [Abstract][Full Text] [Related]
15. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial. Kumar V; Ramesh P; Lodha R; Pandey RM; Kabra SK J Trop Pediatr; 2007 Oct; 53(5):325-30. PubMed ID: 17623754 [TBL] [Abstract][Full Text] [Related]
16. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma. Currie GP; Lee DK; Haggart K; Bates CE; Lipworth BJ Am J Respir Crit Care Med; 2003 May; 167(9):1232-8. PubMed ID: 12456382 [TBL] [Abstract][Full Text] [Related]
17. Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial. Ramsay CF; Sullivan P; Gizycki M; Wang D; Swern AS; Barnes NC; Reiss TF; Jeffery PK Respir Med; 2009 Jul; 103(7):995-1003. PubMed ID: 19249198 [TBL] [Abstract][Full Text] [Related]
18. Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function. Barnes N; Wei LX; Reiss TF; Leff JA; Shingo S; Yu C; Edelman JM Respir Med; 2001 May; 95(5):379-86. PubMed ID: 11392579 [TBL] [Abstract][Full Text] [Related]
19. Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide. Miraglia del Giudice M; Piacentini GL; Capasso M; Capristo C; Maiello N; Boner AL; Capristo AF Respir Med; 2007 Aug; 101(8):1809-13. PubMed ID: 17418554 [TBL] [Abstract][Full Text] [Related]
20. Effects of different anti-asthmatic agents on induced sputum and eosinophil cationic protein in mild asthmatics. Basyigit I; Yildiz F; Kacar Ozkara S; Boyaci H; Ilgazli A; Ozkarakas O Respirology; 2004 Nov; 9(4):514-20. PubMed ID: 15612964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]